Primobolan 25mg
€ 46,00
25 mg · 100 tablets · Oral research compound — Primobolan 25 mg (Methenolone Acetate) is a mild, DHT-based anabolic ideal for lean-mass preservation, nitrogen balance, and catabolic-state models. Its low androgenic and hepatic impact make it suitable for extended protocols with minimal risk.
Brand: Magnus Pharmaceuticals
Content: 100 tablets | 25 mg per tablet
Price: €46
Manufactured in: Europe
Primobolan 25 mg offers researchers an oral DHT-derived anabolic compound with exceptionally low androgenic and hepatic burden. Known scientifically as methenolone acetate, it is widely used in lean-mass preservation, catabolic-state models, and nitrogen-balance studies.
The acetate ester gives Primobolan a short oral half-life (~3–5 hours), requiring twice-daily dosing for stable plasma levels. Its minimal aromatisation, mild androgenicity, and long detection window (>10 days via LC-MS/MS) make it a key substance in cutting-phase protocols and anti-doping method development.
✅ Key Research HighlightsMild androgenic profile: In vitro studies show myotrophic potency exceeding testosterone, yet lower androgenic signaling
Short half-life (oral): 3–5 hours; plasma levels best sustained by ≥2 daily doses
Liver safety: Absence of 17-α-methyl group significantly reduces hepatotoxic risk
Minimal aromatisation: Estrogen conversion is virtually absent, reducing gynecomastia risk
Nitrogen retention: Clinical data confirms reduced urinary nitrogen loss in muscle-wasting states
Anti-doping classification: Long-term urinary metabolites allow detection >10 days post-exposure (WADA S1 listed)
Lean-mass preservation in cutting-phase or post-illness models
Separation of androgenic and estrogenic pathways in body-recomp studies
Anti-doping detection trials with long half-life steroids
Muscle-wasting and catabolic stress research
📊 Technical Specifications| Field | Data |
|---|---|
| Chemical Name | Methenolone Acetate |
| Chemical Formula | C22H32O3 |
| Synonyms | Primobolan, Metenolone Acetate, Nibal |
| Molecular Weight | 344.5 g/mol |
| CAS Number | 434-05-9 |
| Oral Half-life | ≈ 3–5 hours (split dosing required) |
| Detection Window | >10 days (long-term metabolite) |
| Documented Benefits | Lean-tissue preservation, minimal water gain, low androgenic impact |
| Main Risks | HDL↓, testosterone suppression, rare cholestasis |
| Total Active Compound | 2,500 mg per box (25 mg × 100 tablets) |
| Storage / Shelf-life | Store ≤ 25 °C · 36 months (manufacturer specification) |
Effective for nitrogen-balance support and lean-tissue preservation
Minimal hepatic stress compared to alkylated orals
Near-zero aromatisation supports estrogen-sensitive models
Ideal for testing long-range anti-doping detection protocols
⚠️ Documented Research Side EffectsReversible HDL suppression and mild HPG-axis inhibition
Rare reports of cholestasis in long-term exposure
Testosterone suppression in male models
Long-term metabolite excretion (WADA-positive)
🧯 Handling & ComplianceFor Research Use Only — Not for human or veterinary use
Store at 15–25°C, protect from light and moisture
Follow SDS guidelines for safe handling
Purchase confirms qualified researcher status
Related products
Reviews
Clear filtersThere are no reviews yet.